Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Biologics Fill and Finish Services Market by Type (Liquid, Lyophilized), By Application (Clinical Manufacturing, Commercial Manufacturing, Others) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Biologics Fill and Finish Services Market by Type (Liquid, Lyophilized), By Application (Clinical Manufacturing, Commercial Manufacturing, Others) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 173299 3300 IT & Telecom 377 240 Pages 4.7 (43)
                                          

The global biologics fill and finish services market is expected to grow at a CAGR of 7.2% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing demand for biologics in various therapeutic areas such as oncology, immunology, and neurology. Biologics are also being used in combination with other therapies such as chemotherapy or radiation therapy for cancer treatment. The increasing number of clinical trials for new drugs is also driving the growth of this market. Liquid biologics fill and finish services accounted for the largest share in 2018 owing to their higher demand in clinical manufacturing applications due to their ease of use and lower cost compared with lyophilized products. Liquid biologics are preferred over lyophilized products because they can be stored at room temperature without refrigeration or freezing which makes them more convenient than lyophilized products which require cold storage facilities that need constant monitoring by trained personnel.

Some Of The Growth Factors Of This Market:

  1. Biologics Fill and Finish Services market growth is driven by the increasing demand for biologics in the pharmaceutical industry.
  2. The increasing number of biologics being approved by regulatory authorities is also a factor that drives the growth of this market.
  3. The growing number of mergers and acquisitions in the pharmaceutical industry is also a factor that drives this market's growth as it leads to increased demand for fill and finish services from these companies.
  4. Increasing research and development activities in biopharmaceuticals are also driving this market's growth as they lead to an increase in demand for fill and finish services from these companies, which are used to produce final dosage forms such as tablets, capsules, injectables, inhalers etc, from bulk drug substances or active pharmaceutical ingredients (APIs).
  5. Increasing prevalence of chronic diseases such as cancer, diabetes mellitus type 2 etc, is another factor that drives this market's growth because it leads to an increase in demand for biologics which are used to treat these diseases.

Industry Growth Insights published a new data on “Biologics Fill and Finish Services Market”. The research report is titled “Biologics Fill and Finish Services Market research by Types (Liquid, Lyophilized), By Applications (Clinical Manufacturing, Commercial Manufacturing, Others), By Players/Companies Boehringer Ingelheim, Cambrex, Novasep, Vetter, Lonza, Emergent BioSolutions, Cobra Biologics, Catalent, MabPlex, Polpharma Biologics, Baxter Healthcare Corporation, ABL, Inc., Rentschler Fill Solutions, Symbiosis Pharmaceutical Services, iBio”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Biologics Fill and Finish Services Market Research Report

By Type

Liquid, Lyophilized

By Application

Clinical Manufacturing, Commercial Manufacturing, Others

By Companies

Boehringer Ingelheim, Cambrex, Novasep, Vetter, Lonza, Emergent BioSolutions, Cobra Biologics, Catalent, MabPlex, Polpharma Biologics, Baxter Healthcare Corporation, ABL, Inc., Rentschler Fill Solutions, Symbiosis Pharmaceutical Services, iBio

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

240

Number of Tables & Figures

168

Customization Available

Yes, the report can be customized as per your need.


Global Biologics Fill and Finish Services Industry Outlook


Global Biologics Fill and Finish Services Market Report Segments:

The global Biologics Fill and Finish Services market is segmented on the basis of:

Types

Liquid, Lyophilized

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Clinical Manufacturing, Commercial Manufacturing, Others

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Boehringer Ingelheim
  2. Cambrex
  3. Novasep
  4. Vetter
  5. Lonza
  6. Emergent BioSolutions
  7. Cobra Biologics
  8. Catalent
  9. MabPlex
  10. Polpharma Biologics
  11. Baxter Healthcare Corporation
  12. ABL, Inc.
  13. Rentschler Fill Solutions
  14. Symbiosis Pharmaceutical Services
  15. iBio

Global Biologics Fill and Finish Services Market Overview


Highlights of The Biologics Fill and Finish Services Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Liquid
    2. Lyophilized
  1. By Application:

    1. Clinical Manufacturing
    2. Commercial Manufacturing
    3. Others
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Biologics Fill and Finish Services Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Biologics Fill and Finish Services Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Biologics Fill and Finish Services is a process that helps pharmaceutical companies to complete the final steps of the drug development process, including manufacturing and marketing.

Some of the major players in the biologics fill and finish services market are Boehringer Ingelheim, Cambrex, Novasep, Vetter, Lonza, Emergent BioSolutions, Cobra Biologics, Catalent, MabPlex, Polpharma Biologics, Baxter Healthcare Corporation, ABL, Inc., Rentschler Fill Solutions, Symbiosis Pharmaceutical Services, iBio.

The biologics fill and finish services market is expected to register a CAGR of 7.2%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Biologics Fill and Finish Services Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Biologics Fill and Finish Services Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Biologics Fill and Finish Services Market - Supply Chain
   4.5. Global Biologics Fill and Finish Services Market Forecast
      4.5.1. Biologics Fill and Finish Services Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Biologics Fill and Finish Services Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Biologics Fill and Finish Services Market Absolute $ Opportunity

5. Global Biologics Fill and Finish Services Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Biologics Fill and Finish Services Market Size and Volume Forecast by Type
      5.3.1. Liquid
      5.3.2. Lyophilized
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Biologics Fill and Finish Services Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Biologics Fill and Finish Services Market Size and Volume Forecast by Application
      6.3.1. Clinical Manufacturing
      6.3.2. Commercial Manufacturing
      6.3.3. Others
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Biologics Fill and Finish Services Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Biologics Fill and Finish Services Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Biologics Fill and Finish Services Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Biologics Fill and Finish Services Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Biologics Fill and Finish Services Demand Share Forecast, 2019-2026

9. North America Biologics Fill and Finish Services Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Biologics Fill and Finish Services Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Biologics Fill and Finish Services Market Size and Volume Forecast by Application
      9.4.1. Clinical Manufacturing
      9.4.2. Commercial Manufacturing
      9.4.3. Others
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Biologics Fill and Finish Services Market Size and Volume Forecast by Type
      9.7.1. Liquid
      9.7.2. Lyophilized
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Biologics Fill and Finish Services Demand Share Forecast, 2019-2026

10. Latin America Biologics Fill and Finish Services Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Biologics Fill and Finish Services Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Biologics Fill and Finish Services Market Size and Volume Forecast by Application
      10.4.1. Clinical Manufacturing
      10.4.2. Commercial Manufacturing
      10.4.3. Others
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Biologics Fill and Finish Services Market Size and Volume Forecast by Type
      10.7.1. Liquid
      10.7.2. Lyophilized
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Biologics Fill and Finish Services Demand Share Forecast, 2019-2026

11. Europe Biologics Fill and Finish Services Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Biologics Fill and Finish Services Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Biologics Fill and Finish Services Market Size and Volume Forecast by Application
      11.4.1. Clinical Manufacturing
      11.4.2. Commercial Manufacturing
      11.4.3. Others
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Biologics Fill and Finish Services Market Size and Volume Forecast by Type
      11.7.1. Liquid
      11.7.2. Lyophilized
   11.8 Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Biologics Fill and Finish Services Demand Share, 2019-2026

12. Asia Pacific Biologics Fill and Finish Services Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Biologics Fill and Finish Services Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Biologics Fill and Finish Services Market Size and Volume Forecast by Application
      12.4.1. Clinical Manufacturing
      12.4.2. Commercial Manufacturing
      12.4.3. Others
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Biologics Fill and Finish Services Market Size and Volume Forecast by Type
      12.7.1. Liquid
      12.7.2. Lyophilized
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Biologics Fill and Finish Services Demand Share, 2019-2026

13. Middle East & Africa Biologics Fill and Finish Services Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Biologics Fill and Finish Services Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Biologics Fill and Finish Services Market Size and Volume Forecast by Application
      13.4.1. Clinical Manufacturing
      13.4.2. Commercial Manufacturing
      13.4.3. Others
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Biologics Fill and Finish Services Market Size and Volume Forecast by Type
      13.7.1. Liquid
      13.7.2. Lyophilized
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Biologics Fill and Finish Services Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global Biologics Fill and Finish Services Market: Market Share Analysis
   14.2. Biologics Fill and Finish Services Distributors and Customers
   14.3. Biologics Fill and Finish Services Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. Boehringer Ingelheim
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Cambrex
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Novasep
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Vetter
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. Lonza
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Emergent BioSolutions
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. Cobra Biologics
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. Catalent
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. MabPlex
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. Polpharma Biologics
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. Baxter Healthcare Corporation
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. ABL, Inc.
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. Rentschler Fill Solutions
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. Symbiosis Pharmaceutical Services
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. iBio
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us